Some Biologic Treatments for Psoriasis May Be Safer for Patients
An observational cohort study suggests there is less risk of serious infection in patients taking newer, targeted systemic medications for psoriasis.
An observational cohort study suggests there is less risk of serious infection in patients taking newer, targeted systemic medications for psoriasis.
Concerns about skin flap viability have long kept many surgeons from combining these procedures. A new case series takes a closer look at whether that caution is still warranted.